Andreanne N. Zizzo

Donor type, social deprivation, and long‑term outcomes in pediatric liver transplantation: A 30‑year population‑based cohort.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 26, 2026

Condition-Specific Growth Charts for Children With Alagille Syndrome.

Journal: JAMA network open

Published: November 24, 2025

Socioeconomic Disparities in Long-Term Outcomes After Pediatric Liver Transplantation in a Universal Healthcare System: A Population-Based Study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: November 16, 2025

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 14, 2025

Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation.

Journal: Journal of clinical immunology

Published: February 26, 2025

Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 03, 2025

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.

Journal: Hepatology (Baltimore, Md.)

Published: November 29, 2021

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.

Journal: Journal of pediatric gastroenterology and nutrition

Published: August 03, 2020

Donor type, social deprivation, and long‑term outcomes in pediatric liver transplantation: A 30‑year population‑based cohort.

Donor type, social deprivation, and long‑term outcomes in pediatric liver transplantation: A 30‑year population‑based cohort.

Condition-Specific Growth Charts for Children With Alagille Syndrome.

Condition-Specific Growth Charts for Children With Alagille Syndrome.

Socioeconomic Disparities in Long-Term Outcomes After Pediatric Liver Transplantation in a Universal Healthcare System: A Population-Based Study.

Socioeconomic Disparities in Long-Term Outcomes After Pediatric Liver Transplantation in a Universal Healthcare System: A Population-Based Study.

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation.

Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation.

Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.

Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.

Home-based fecal calprotectin utilization in a general pediatric gastroenterology clinic.

Home-based fecal calprotectin utilization in a general pediatric gastroenterology clinic.

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.

Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.

Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.